Merck Introduces Aptegra CHO genetic stability assay for accelerated biosafety testing

Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind.

Pediatric Allergic March Supported by Nationwide EHR Data

A typical allergic march started with atopic dermatitis during infancy and progressed to other allergies later in life, a multi-state study found. In total, 13.4%

July 27, 2023

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Health care providers and their patients could know with greater confidence whether pancreatic cysts are benign or potentially malignant, and if surgery is required to

July 12, 2023

Illumina’s pitch for new machines: You, too, can sequence DNA

Can Illumina win over labs that have never tried DNA sequencing? The company on Wednesday unveiled what it called its simplest machines yet for parsing

October 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.